Measuring outcomes in fertility trials: can we rely on clinical pregnancy rates?
Author:
Publisher
Elsevier BV
Subject
Obstetrics and Gynaecology,Reproductive Medicine
Reference28 articles.
1. What is the most relevant standard of success in assisted reproduction? The singleton, term gestation, live birth rate per cycle initiated: the BESST endpoint for assisted reproduction;Min;Hum Reprod,2004
2. Risks and complications in assisted reproduction techniques: report of an ESHRE consensus meeting;Land;Hum Reprod,2003
3. Bennebroek Gravenhorst J, Buitendijk SE. Evaluation of 280,000 cases in Dutch midwifery practices: a descriptive study;Amelink-Verburg;BJOG,2008
4. No more surrogate end-points in randomised trials—the PCOSMIC trial protocol for women with polycystic ovary syndrome using metformin for infertility with clomiphene;Johnson;Aust N Z J Obstet Gynaecol,2006
5. Human Fertilization and Embryology Authority. Available at http://www.hfea.gov.uk/en/default.html. Last accessed September 15, 2010.
Cited by 54 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Endometrial compaction to predict pregnancy outcomes in patients undergoing assisted reproductive technologies: a systematic review and meta-analysis;Human Reproduction Open;2024
2. Effectiveness of recombinant human follicle-stimulating hormone (r-hFSH):recombinant human luteinizing hormone versus r-hFSH alone in assisted reproductive technology treatment cycles among women aged 35–40 years: a German database study;Reproductive BioMedicine Online;2023-11
3. Correlation between acupuncture dose and pregnancy outcomes in women with Polycystic ovary syndrome undergoing in vitro fertilization-embryo transfer: a systematic review;2023-08-18
4. WITHDRAWN:Â Effectiveness of recombinant human follicle-stimulating hormone (r-hFSH): recombinant human luteinizing hormone versus r-hFSH alone in assisted reproductive technology treatment cycles among women aged 35–40 years: A German database study;Best Practice & Research Clinical Obstetrics & Gynaecology;2023-07
5. Clinical outcomes in patients receiving originator follitropin alfa and follitropin alfa biosimilars in real-world clinical practice: A retrospective study;Journal of Human Reproductive Sciences;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3